Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL PROBIOTIC COMPOSITION FOR REGULATION OF INTESTINAL IMMUNITY
Document Type and Number:
WIPO Patent Application WO/2020/262755
Kind Code:
A1
Abstract:
The present invention relates to a novel probiotic composition for regulation of intestinal immunity and, more specifically, to a composition including Lactobacillus johnsonii, Lactobacillus plantarum, and Bifidobacterium animalis subspecies lactis as active ingredients for suppressing inflammation and/or preventing, ameliorating, or treating inflammatory intestinal diseases,

Inventors:
MOON JIN SEOK (KR)
KIM TAE-YOON (KR)
KWON HYUK-SANG (KR)
Application Number:
PCT/KR2019/009117
Publication Date:
December 30, 2020
Filing Date:
July 23, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
IL DONG PHARMA (KR)
International Classes:
A61K35/747; A23L33/135; A61P1/00; A61P29/00
Foreign References:
KR20140037544A2014-03-27
KR20150095717A2015-08-21
KR20190048739A2019-05-09
KR20190077422A2019-07-03
Other References:
CHINA ECONOMIC NET: "South Korea develops new probiotics that may improve symptoms of irritable bowel syndrome", 27 September 2018 (2018-09-27), pages 1 - 3, XP009532625, Retrieved from the Internet
ANONYMOUS: "Intercourse. Intestinal Health of People Protected by Probiotics Today.", 25 October 2018 (2018-10-25), pages 1 - 4, Retrieved from the Internet
ILDONGPHARMACEUTICAL CO., LTD. ET AL.: "Final report on the development and global branding of Korean probiotics effective for irritable bowel syndrome ", FINAL REPORT, 25 September 2019 (2019-09-25), Korea, pages 1 - 351, XP009532633
JE IN-GYU, LEE DON-GIL, JEONG DONG-GU, HONG DAHAE, YOON JONG-MIN, MOON JIN SEOK, PARK SOOBONG: "The probiotic, ID-JPL934, attenuates dextran sulfate sodium-induced colitis in mice through inhibition of proinflammatory cytokines expression.", JOURNAL OF MEDICINAL FOOD., vol. 21, no. 9, 23 July 2018 (2018-07-23), pages 858 - 865, XP055778837
JE IN-GYU, LEE DON-GIL, JEONG DONG-GU, HONG DAHAE, YOON JONG-MIN, MOON JIN SEOK, PARK SOOBONG: "The probiotic, ID-JPL934, attenuates dextran sulfate sodium-induced colitis in mice through inhibition of proinflammatory cytokines expression.", POSTER NO. C041, IN: 2019 INTERNATIONAL MEETING OF THE MICROBIOLOGICAL SOCIETY OF KOREA ., 17 April 2019 (2019-04-17), Jeju, Korea, pages 858 - 865, XP055778837
SHIN CHEOL MIN; CHOI YOON JIN; LEE DONG HO; YOON HYUK; PARK YOUNG SOO; KIM NAYOUNG: "Sa1951 - Validity and Safety of Symptom Improvement of Id-Jpl934 for Abnormal Bowel Movements Such As Constipation, Diarrhea, Abdominal Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial", GASTROENTEROLOGY, vol. 156, no. 6, 18 May 2019 (2019-05-18), pages S-466 - S-466, XP085678040, ISSN: 0016-5085, DOI: 10.1016/S0016-5085(19)38017-5
ATREYA RZIMMER MBARTSCH B ET AL.: "Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14(+) macrophages", GASTROENTEROLOGY, vol. 141, 2011, pages 2026 - 2038, XP028118482, DOI: 10.1053/j.gastro.2011.08.032
COCCIA MHARRISON OJSCHIERING C ET AL.: "IL-1 beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells", J EXP MED, vol. 209, 2012, pages 1595 - 1609
WANG YWANG KHAN GC ET AL.: "Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis", MUCOSAL IMMUNOL, vol. 7, 2014, pages 1106 - 1115
See also references of EP 3991739A4
Attorney, Agent or Firm:
LEE, Hee Sook (KR)
Download PDF: